Research programme: therapeutic vaccines - Immunovo

Drug Profile

Research programme: therapeutic vaccines - Immunovo

Alternative Names: Anti-PD-L1 vaccine - Immunovo; Anti-sclerostin vaccine - Immunovo

Latest Information Update: 24 May 2016

Price : $50

At a glance

  • Originator Immunovo
  • Class Vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Research Bone disorders; Cancer

Most Recent Events

  • 06 Apr 2015 Early research in Bone disorders in Netherlands (unspecified route)
  • 05 Apr 2015 Early research in Cancer in Netherlands (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top